Michigan authorities say several seizure-inducing overdoses have been traced to a synthetic cannabis solution called "Darth Vapor" used in e-cigarettes.
California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients.
Novartis' investigational combination indacaterol/glycopyrronium bromide therapy for COPD performed better than its constituent components in a Phase III clinical trial.
For a small percentage of chronic lung disease patients, the environment -- not smoking or genetics -- plays the primary role in their development of the disease.
Emergency departments will feel negative impacts from the changeover to the new ICD-10 coding system, which will have more than 68,000 codes.
Several cases among a multistate outbreak of variant influenza A (H3N2) in 2012 may have resulted from swine exposure during an Ohio agricultural fair.
Research presented at the 2015 American Thoracic Society (ATS) International Conference indicates that living in a rural area and being poor are risk factors for COPD.
According to new research, COPD is associated with an increased risk of dying from a cardiovascular disease, such as heart failure, as well as conditions not associated with the heart.
A combination of the drugs Kalydeco (ivacaftor) and lumacaftor successfully treated the defective CF protein, improved lung function, and helped reduce pulmonary exacerbations by 40%.
New plans designed to cut costs and improve patient care involve using specially trained paramedics in order to reduce avoidable trips to the emergency room.
A new study reveals that methylprednisolone and budesonide inhalation suspension showed limited differences in young patients with bronchial asthma attacks.
A fresh alert has been issued for Middle East respiratory syndrome by the Saudi Health Ministry, as 12 new cases were reported between May 10 and May 16.
According to new data, the use of ibuprofen or acetaminophen did not affect the length of a hospital stay for children with asthma.
In three clinical trials, Genentech's new idiopathic pulmonary fibrosis drug Esbriet (pirfenidone) significantly reduced loss of lung function in nearly 50% of participants.
Regeneron Pharmaceuticals and Sanofi revealed positive results from a study of dupilumab in adult patients with asthma.
Percepta Bronchial Genomic Classifier, a new diagnostic test from Veracyte Inc, can assess a person's risk for lung cancer.
Results from the 6-month STELVIO trial validated the safety and efficacy of the Pulmonx Zephyr Endobronchial Valve (EBV) in severe emphysema patients.
The school-based program “Building Bridges for Asthma Care” significantly decreased school absenteeism among children with asthma in inner-city schools enrolled in the program.
Regular aspirin use was associated with a significantly slower progression of percent emphysema over 10 years, when compared to those who did not use aspirin.
Treatment of COPD with inhaled corticosteroids may decrease the risk of dying from pneumonia despite being linked with an increase in pneumonia occurrence.